Lyon, France—June 2017 – Mapi Research Trust, the leading curator and license distributor of Clinical Outcome Assessments (COAs) and Mapi Language Services, the most trusted provider of linguistic validation of COAs, will present three posters at the 21st International Congress of Parkinson's Disease and Movement Disorders (MDS) which will be held in Vancouver (Canada) from June 4th to 8th 2017:
- “The Role of Clinical Outcome Assessment (COA) Data in the Drug Approval Process of Medicines for the Treatment of Restless Legs Syndrome (RLS): A Review of the Labels of Medicines Approved by the FDA and the EMA”
- “Translating the Parkinson´s Disease Sleep Scale (PDSS-2) into 31 Languages Using a Standardized Methodology”, in collaboration with K Ray Chaudhuri and Claudia Trenkwalder
- Translating the Rapid Eye Movement (REM) Sleep Behavior Disorder Screening Questionnaire (RBDSQ) into 21 Languages Using a Standardized Methodology”, in collaboration with Prof. Dr. Karin Stiasny-Kolster
Mapi Research Trust, as the largest single COA licensing provider, and Mapi Language Services share their experience in movement disorders and Parkinson’s disease on renowned rating scales and their translations distributed by Mapi Research Trust on behalf of their developers and copyright holders including; the Parkinson´s Disease Sleep Scale (PDSS-2), the Rapid Eye Movement (REM) Sleep Behavior Disorder Screening Questionnaire (RBDSQ), the King's Parkinson's Disease Pain Scale (KPPS), the Parkinson's Disease Quality of Life Questionnaire (PDQL), and many others.
To learn more about Mapi or to meet us at the MDS conference, please contact Marie-Pierre Emery: firstname.lastname@example.org
About Mapi Language Services:
Mapi Language Services is the worldwide leader in medical translation and Linguistic Validation of COAs for nearly 3 decades. Mapi has first-hand knowledge of local languages and cultures, regulations, and healthcare practices. Mapi Language Services’ experience represents more than 40,000 translated versions of 2,500 Questionnaires in 170 languages. Visit https://www.mapigroup.com for more information.
About Mapi Research Trust:
Mapi Research Trust is a Non-Profit arm of Mapi Group and works in collaboration with Academic Researchers, Life-Science Companies and Regulatory bodies. It is the largest curator of Clinical Outcomes Assessments (COAs) and their translations, the largest single COA licensing provider and the most trusted name in distribution of COA instruments exclusively representing over 300 questionnaires. Visit http://mapi-trust.org/.
Press contact: Media@mapigroup.com